These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 23355243)
1. [Association between miR-34a expression and recurrence after radical resection of colorectal cancer]. Li S; Li YY; Gao J; Shen L Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):60-5. PubMed ID: 23355243 [TBL] [Abstract][Full Text] [Related]
2. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853 [TBL] [Abstract][Full Text] [Related]
3. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481 [TBL] [Abstract][Full Text] [Related]
5. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy]. Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069 [TBL] [Abstract][Full Text] [Related]
6. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer]. Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455 [TBL] [Abstract][Full Text] [Related]
7. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer]. Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of miR-195 with invasiveness and prognosis of breast cancer]. Song CG; Wu XY; Wang C; Fu FM; Shao ZM Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
12. Circulating miR-34a levels are reduced in colorectal cancer. Nugent M; Miller N; Kerin MJ J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological characteristics and prognosis of patients with recurrent colorectal cancer]. Song XM; Yang ZL; Wang L; Wang JP; Zhan WH; He YL; Huang YH; Lan P Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):492-4. PubMed ID: 17143792 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients. Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128 [TBL] [Abstract][Full Text] [Related]
16. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060 [TBL] [Abstract][Full Text] [Related]
17. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA. Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735 [TBL] [Abstract][Full Text] [Related]
18. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microRNA-148a in patients with early relapse of stage II stage and III colorectal cancer after curative resection. Tsai HL; Yang IP; Huang CW; Ma CJ; Kuo CH; Lu CY; Juo SH; Wang JY Transl Res; 2013 Oct; 162(4):258-68. PubMed ID: 23933284 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of colorectal carcinoma in the elderly after radical surgery]. Liang JW; Bai XF; Zhou ZX; Zhao DB; Wang CF; Zhao P Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1467-70. PubMed ID: 18953852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]